Frequently Asked Questions
The market is segmented based on Global Drug Safety Solutions and Pharmacovigilance Market, By Type (Software and Services), Product (Standard Form and Customized Form), Functionality (Adverse Event Reporting Software, Drug Safety Audits Software, and Issue Tracking Software), Delivery (On-Premise Delivery Mode and On-Demand/Cloud-Based (SAAS) Delivery Mode), End Users (Biotechnology and Pharmaceuticals, Contract Research Organizations (CROS), Hospitals, KPOs/BPOs, and Healthcare Providers), Distribution Channel (Direct Sales and Retail Sales) – Industry Trends and Forecast to 2031.
.
The Global Drug Safety Solutions And Pharmacovigilance Market size was valued at USD 8.39 USD Billion in 2023.
The Global Drug Safety Solutions And Pharmacovigilance Market is projected to grow at a CAGR of 7.5% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
